The Week in Review: March 17, 2017 – March 24, 2017

Friday, March 24, 2017 News Recap Well, if you've been up to our site and seen the daily news posts you will have seen that new drug access policies have now come into effect in BC and Quebec, as well as Ontario. It looks like the slate is the same for these 3 provinces, and we are listing what's available in BC so you can make sense of it.  For more information on the expanded access criteria in Quebec see here, and in particular the note from CD. ...

Selkirk College Student Nurses Bring HEPCBC and ANKORS to Hepatitis C Info Event

HepCBC was thrilled to get an invitation to a Selkirk College student nurse-initiated seminar in Castlegar, BC March 20, 2017. Robin Tomlin, HepCBC Board Member from nearby Robson, coordinated with the students, Janelle Jaworenko and Katrina Verigin, and their instructor Tammy McLean. Robin joined our President, Rosemary Plummer, RN, and Volunteer Cheryl Reitz for the day. Starting at 8 am sharp, we presented "Hepatitis C 101," bringing in all the latest

British Columbia lists EPCLUSA™ on public drug plan to treat all six genotypes of chronic hepatitis C infection

-- British Columbia Also Broadens Access for Patients with Less Advanced Disease Who Have Other Health Conditions -- MISSISSAUGA, ON, March 21, 2017 /CNW/ - Gilead Sciences Canada, Inc. (Gilead Canada) today announced, effective March 21, 2017, British Columbia will provide public access to EPCLUSA™ (sofosbuvir/velpatasvir) tablets, the first once-daily, pan-genotypic single tablet regimen for the treatment of adults with genotype 1-6 chronic hepatitis C ...

ZEPATIER® now covered in Quebec for the treatment of chronic hepatitis C

KIRKLAND, QC, March 21, 2017 /CNW Telbec/ - Merck Canada Inc. today announced that ZEPATIER® (elbasvir/grazoprevir) will be listed among the drugs covered by Quebec's health insurance board, the Régie de l'assurance maladie du Québec (RAMQ), as of March 22. Quebec joins other jurisdictions that have approved the product for reimbursement under their public healthcare plans for chronic hepatitis C patients presenting with recognized criteria. Zepatier is i

Canada needs Hepatitis C testing strategy, says N.W.T. MP

Michael McLeod wants Health Canada to step up efforts to educate people about Hep C testing. "This is an issue that's curable... I'm going to stay on this issue and continue to push the fact that we need a strategy," says Liberal N.W.T. MP Michael McLeod. The MP for the Northwest Territories is calling on the federal government to develop a national Hepatitis C education strategy. McLeod said the Northwest Territories has one of the highest rates of He

New Hepatitis C Drugs Might Eliminate the Disease

But not everyone responds completely to the medicines and cost remains a big obstacle, researchers say MONDAY, March 20, 2017 (HealthDay News) -- Newer treatments for hepatitis C appear to eliminate the virus in the vast majority of those taking oral antiviral medications, raising the hope that this disease might someday be eradicated in the United States. The oral medications "work really well in most patients that have hepatitis C," said Dr. Oluwaseu

EPCLUSA™, to treat all six genotypes of chronic hepatitis C infection, added to the Liste des médicaments de la RAMQ (Quebec)

-- Quebec Broadens Access for Patients with Less Advanced Disease Who Have Other Health Conditions -- MISSISSAUGA, ON, March 20, 2017 /CNW/ - Gilead Sciences Canada, Inc. (Gilead Canada) commends the continued leadership of Quebec in the treatment of hepatitis C with the listing of EPCLUSA™ (sofosbuvir/velpatasvir) tablets effective on March 22, 2017.  EPCLUSA is the first once-daily, pan-genotypic single tablet regimen for the treatment of adults with g...

The Week in Review: March 10, 2017 – March 17, 2017

Friday, March 17, 2017 News Recap Top of the news this week is a report from Cheryl Reitz who has just embarked on another Outreach Road Trip to BC's rural, remote, and First Nations communities.  The report this week covers Lytton, Spences Bridge and Cache Creek. The report is very detailed and we have included a slide show. Rural/Remote/Indigenous Hepatitis C Outreach 2017 – Part 1 Other News: Will they ever learn? Many years ago several senior...

Rural/Remote/Indigenous Hepatitis C Outreach 2017 – Part 1

HepCBC considers outreach to BC's rural, remote, and First Nations communities one of our most important roles as advocates for hepatitis C treatment equity. This year started with a trip to a Prince George health fair and a webinar with the BC Centre for Disease Control comparing HCV treatment and care in BC'S urban vs rural populations. The outreach is continuing this week (March 14-19) into the Interior with Cheryl Reitz' Greyhound bus trip to Lytto...

Inappropriate syringe reuse led to hep C transmission in Texas hospital, CDC says

Note from CD: Many years ago several seniors in a hospital in Florida were infected this way because inserting the syringe into the intravenous line cause a back pressure leak that forced solution into the syringe, and this infected solution was then shared. The news item from many years ago has disappeared, but many HCV advocates remember this event.  If you have the source please contact us at HepCBC. A nurse in a Texas hospital mistakenly believed sali